All-In

We have a policy to "do no harm," but instead we should be aiming to "do more good." For example, we could use a drug that might kill 2% of the people that take it, but 80% of the people who were otherwise going to die, would not live. That's a much better outcome, but we can't do it right now due to regulations.

We have the science and the manufacturing capacity to do it, but regulatory hurdles in America are preventing scientists from actually doing it. As a result, people do not have a choice to decide whether they want to use a certain drug or not.

Even Remdesivir, the drug that seems to be helping with Covid-19 and does not have any mortality associated with it, people cannot simply get it at the hospital.

0:00
0:00